• Viral infections

Virazole Generic Name & Formulations

General Description

Ribavirin 6g/vial; pwd for reconstitution and aerosol inhalation.

Pharmacological Class

Nucleoside analogue.

How Supplied


Virazole Indications


Severe lower respiratory infections due to respiratory syncytial virus in hospitalized infants and young children.

Virazole Dosage and Administration


Not recommended.


Begin treatment preferably within first 3 days of infection. 20mg/mL as starting solution in drug reservoir for continuous aerosol administration for 12–18 hours per day for 3–7 days.

Virazole Contraindications


Pregnancy (Cat.X).

Virazole Boxed Warnings

Boxed Warning

Should be undertaken only by experienced physicians and support staff. Sudden deterioration of respiratory function in infants. Not indicated for use in adults.

Virazole Warnings/Precautions


See full labeling. Monitor respiratory function, fluid status. Discontinue if sudden deterioration of respiratory function. Use with mechanical ventilators should be undertaken only by physicians and support staff familiar with this mode of administration. Drug may precipitate in mechanical ventilator, causing dysfunction. Avoid unnecessary occupational exposure. Nursing mothers.

Virazole Pharmacokinetics

See Literature

Virazole Interactions


Monitor digitalis.

Virazole Adverse Reactions

Adverse Reactions

Pulmonary function deterioration, bronchospasm, pulmonary edema, hypoventilation, bacterial pneumonia, pneumothorax, apnea, ventilator dependence, atelectasis, cardiac arrest, hypotension, reticulocytosis, hemolytic anemia, rash, conjunctivitis.

Virazole Clinical Trials

See Literature

Virazole Note

Not Applicable

Virazole Patient Counseling

See Literature